Tobira Therapeutics, Inc. Operating Cash Flow
Tobira Therapeutics, Inc. reported Operating Cash Flow of -$52.67 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2015-02-12
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2014-12-31 was -$8.62M.
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2014-09-30 was -$11.32M.
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2014-06-30 was -$19.31M.
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2014-03-31 was -$13.42M.
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2014 was -$52.67M.
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2013 was -$34.74M.
- Tobira Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2012 was -$14.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 142 month | Net Cash Provided by (Used in) Operating Activities 145 month | Net Cash Provided by (Used in) Operating Activities 148 month |
|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$19.94M derived: sum of 2 quarters · filed 2015-02-12 | -$39.25M derived: sum of 3 quarters · filed 2015-02-12 | -$52.67M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | -$11.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$30.63M derived: sum of 2 quarters · filed 2014-11-06 | -$44.05M 10-Q · filed 2014-11-06 | -$56.66M derived: sum of 4 quarters · filed 2014-11-06 | |||
| 2014-06-30 | -$19.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$32.73M 10-Q · filed 2014-08-11 | -$45.34M derived: sum of 3 quarters · filed 2014-08-11 | -$58.94M derived: sum of 4 quarters · filed 2014-11-06 | |||
| 2014-03-31 | -$13.42M 10-Q · filed 2014-05-13 | -$26.03M derived: sum of 2 quarters · filed 2014-05-13 | -$39.63M derived: sum of 3 quarters · filed 2014-11-06 | -$45.01M derived: sum of 4 quarters · filed 2014-11-06 | -$153.83M 10-Q · filed 2014-05-13 | ||
| 2013-12-31 | -$12.61M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$26.22M derived: sum of 2 quarters · filed 2014-11-06 | -$31.59M derived: sum of 3 quarters · filed 2014-11-06 | -$34.74M 10-K · filed 2014-03-12 | -$140.17M 10-K · filed 2014-03-12 | ||
| 2013-09-30 | -$13.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$18.98M derived: sum of 2 quarters · filed 2014-11-06 | -$22.13M 10-Q · filed 2014-11-06 | -$25.79M derived: sum of 4 quarters · filed 2014-11-06 | -$127.98M 10-Q · filed 2013-11-08 | ||
| 2013-06-30 | -$5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$8.52M 10-Q · filed 2014-08-11 | -$12.18M derived: sum of 3 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | -$3.14M 10-Q · filed 2014-05-13 | -$6.80M derived: sum of 2 quarters · filed 2014-05-13 | |||||
| 2012-12-31 | -$3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$14.23M 10-K · filed 2014-03-12 | |||||
| 2012-09-30 | -$10.57M 10-Q · filed 2013-11-08 |